Eulerpool Terminal
The edge that pays for itself.
Current ProQR Therapeutics forecasts and price targets in August 2026
Ø Analyst Price Targets
8.50 EUR
+377.46 %
Median
8.39 EUR
+371.26 %
Max
14.70 EUR
Min
5.05 EUR
Last Price
1.78 EUR
Buy
14
Hold
1
Sell
0
The average target price for ProQR Therapeutics is 8.50 EUR. (+377.46 % above the current price)
The median price target of ProQR Therapeutics is 8.39 EUR.
Stock analysts from many renowned investment banks are closely examining the ProQR Therapeutics stock. They conclude their professional ProQR Therapeutics stock analyses with a clear recommendation for the ProQR Therapeutics stock. The forecasts and price targets of professional analysts can be a good indicator of how a stock will perform in the next quarter.
| Buy | Hold | Sell | Ø Analyst Price Targets | |
|---|---|---|---|---|
| 2026-02-01 | 14 | 1 | 0 | 8.50 EUR |
| 2026-01-01 | 14 | 1 | 0 | 8.50 EUR |
| 2025-12-01 | 14 | 1 | 0 | 8.45 EUR |
| 2025-12-01 | 14 | 1 | 0 | 8.50 EUR |
| 2025-11-01 | 14 | 1 | 0 | 8.50 EUR |
| 2025-11-01 | 14 | 1 | 0 | 7.95 EUR |
ProQR Therapeutics Stock Forecast 2026: Revenue & Earnings Estimates
Analysts expect the following revenue and earnings for ProQR Therapeutics in the coming fiscal years:
| Fiscal year | Revenue | Net Income | Earnings per share |
|---|---|---|---|
| 2025e | 16.00 M EUR | -42.00 M EUR | -0.49 EUR |
| 2026e | 13.00 M EUR | -48.00 M EUR | -0.56 EUR |
| 2027e | 17.00 M EUR | -52.00 M EUR | -0.60 EUR |